Stay Updated
For all press requests, please reach out to [email protected].
News and Reports
Merith Basey, CEO of Patients for Affordable Drugs, warned in a statement that “while these tariffs aim to pressure pharmaceutical corporations into US manufacturing and most favored nation agreements, the current MFN deals remain opaque and voluntary, and have not delivered meaningful savings for the vast majority of American patients. There’s a real risk these […]
News and Reports
POLITICO Prescription Pulse: Patients for Affordable Drugs has added two people to its board
Patients for Affordable Drugs has added two people to its board: Utibe Essien, internal medicine physician and assistant professor of medicine at UCLA, and Jesse Fuchs-Simon, a Philadelphia-based real estate developer and attorney.
Press Releases
Patients For Affordable Drugs Responds to Trump’s Announcement On Tariffs
WASHINGTON, DC – Following President Trump’s announcement of sweeping tariffs of up to 100% on imported brand-name prescription drugs and their ingredients, Patients For Affordable Drugs CEO Merith Basey released the following statement: “While these tariffs aim to pressure pharmaceutical corporations into U.S. manufacturing and Most Favored Nation agreements, the current MFN deals remain opaque and voluntary, and have […]
Press Releases
WASHINGTON, D.C. — Patients For Affordable Drugs today announced the addition of new leaders to its board of directors, further strengthening the organization’s expertise and continued growth. “Our new board members bring a depth of knowledge across medicine, law, public health, and business, along with patient experience — exactly the expertise this fight demands,” said Merith Basey, CEO […]
News and Reports
InsideHealthPolicy: DOJ Defends Drug Negotiation Program In Latest SCOTUS Brief
“What’s notable here is the broader signal it sends about the program’s staying power. Despite sustained opposition from the industry it’s proven durable across administrations,” a spokesperson for the group Patients for Affordable Drugs said. “This brief is the clearest signal yet that Medicare negotiation is not only being upheld, but reinforced as a central […]
Press Releases
New P4AD Analysis: Pharma Hikes Prices on Cancer Drugs, While Lobbying to Obstruct Reform
Analysis is part of a new series on Pharma-driven price hikes of essential medicines WASHINGTON, D.C. — Patients For Affordable Drugs released a new analysis showing that drugmakers are raising prices on lifesaving oncology medications while lobbying to delay Medicare Drug Price Negotiation programs — reinforcing a pattern of price hikes alongside efforts to weaken reforms. In the […]
Press Releases
Analysis is part of a new series on Pharma-driven price hikes of essential medicines WASHINGTON, D.C. — Patients For Affordable Drugs is releasing a new analysis finding that pharmaceutical companies raised prices on rare disease drugs just a few months after the passage of the ORPHAN Cures Act in the 2025 Reconciliation Package, which weakened […]
Press Releases
WASHINGTON, D.C. — Patients For Affordable Drugs (P4AD) filed its sixth patient-centered amicus brief defending the Medicare Negotiation Program, this time in the District of Columbia U.S. Court of Appeals, where Teva Pharmaceuticals is appealing its failed attempt to strike down the program. The brief underscores the real-world impact of lower prices for patients and responds to legal […]